Humana (STO:HUM) Full Year 2024 Results
Key Financial Results
- Revenue: kr10.3b (up 6.8% from FY 2023).
- Net income: kr144.0m (down 18% from FY 2023).
- Profit margin: 1.4% (down from 1.8% in FY 2023). The decrease in margin was driven by higher expenses.
- EPS: kr2.87 (down from kr3.68 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Humana EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.2%.
Looking ahead, revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Healthcare industry in Sweden.
Performance of the Swedish Healthcare industry.
The company's shares are down 3.7% from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Humana (1 doesn't sit too well with us!) that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Humana might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:HUM
Humana
Provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark.
Undervalued with proven track record.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives
Micron Technology will experience a robust 16.5% revenue growth
Amazon will rebound as AI investments start paying off by late 2026

Inside Harvey Norman: Asset-Heavy Retail in an Online World
Popular Narratives

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
